“Efficiency Integrated Chemotherapy With EGFR Receptor Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer and an Activating EGFR Gene Mutation”. Voprosy onkologii 67, no. 2 (May 6, 2022): 246–253. Accessed October 14, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/651.